Use of M-M-R II outside of the routinely recommended age range – a systematic literature review

Use of M-M-R II outside of the routinely recommended age range – a systematic literature review

M-M-R®II (M-M-R II) is routinely used in many countries at 12–15 months with a second dose at 4 to 6 years of age. However, the vaccine may need to be administered at other ages due to delays in the immunization schedule or in certain situations such as outbreaks or international travel. A systemati...

Full description

Bibliographic Details
Main Authors: Manjiri Pawaskar, Elvira Schmidt, Gary S. Marshall, Jaime Fergie, Elizabeth Richardson, Louise Parks Saldutti, Se Li, Monika Neumann, Linnea Koller, Barbara Kuter
Format: Article
Language:English
Published: Taylor & Francis Group 2022-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
mmr vaccine
measles
mumps
rubella
efficacy
immunogenicity
safety
age
infants
Online Access:http://dx.doi.org/10.1080/21645515.2021.1933874

Internet

http://dx.doi.org/10.1080/21645515.2021.1933874

Similar Items